The influence of antistine on glycogenolytic effect of some biogenic amines in rat brain slices.
D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001679:Biogenic Amines / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002087:Butyrates / Q000494:pharmacology; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D006003:Glycogen / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013268:Stimulation, Chemical; D013788:Thalamus / Q000187:drug effects / Q000378:metabolism
D000814:Aniline Compounds; D001593:Benzyl Compounds; D001679:Biogenic Amines; D002087:Butyrates; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D012701:Serotonin; D006632:Histamine; D006003:Glycogen; D000242:Cyclic AMP; D004298:Dopamine; D009638:Norepinephrine